Two drugs have been approved for Expanded Access, or “compassionate use”, by the FDA to treat COVID-19, the disease caused by the CCP virus. What are they and how do they work? Why should the virus be referred to as the CCP virus?
In this episode of Zooming In, Simone Gao discusses these questions with Dr. Sean Lin, former lab director of the Viral Disease Branch, Walter Reed Army Institute of Research.
Official website: https://www.ntd.com/zooming-in
Follow Simone on Twitter: @ZoomingIn_NTD.